On Thursday, TSCL delivered letters to several congressional offices – including the offices of lawmakers on the House Ways and Means Committee and the Senate Finance Committee – requesting support for three tax-related changes that would strengthen the Social Security program: .The fate of President Obama's controversial executive action on immigration remains tied up in court. The potential long-term financial impact of the actions on Social Security and Medicare remains unknown, and elected lawmakers have been unable to agree to immigration policy changes legislatively. ."Switching to a more slowly growing CPI is not the only change affecting seniors that deficit negotiators are looking at," notes Hyland. "Members of Congress from both parties are already considering changes that would make seniors pay a bigger share of their Medicare, and reducing government Medicaid payments at the same time," he adds. ."Brand-name drugs are the primary driver of the higher prescription drug prices in the U.S.," report co-author Andrew Mulcahy said in a press release. .The benefit reduction would be caused by a feature of the Social Security benefit formula that is sensitive to economic recessions and high unemployment. The first step in calculating benefits is to adjust the individual's earnings using the average wage index (AWI) in order to convert the value of past earnings into today's dollars. The AWI is also used to adjust the earnings levels that determine the portion of their average monthly earnings that people are allowed to keep as their benefit. .That spells trouble for people living on fixed incomes. "When COLAs fall down on the job of protecting benefit buying power, seniors face working longer, digging deeper into retirement savings, or falling into debt and poverty," says Ed Cates, Chairman of TSCL. .Single — your annual income is less than ,090 (,507.50 per month) and resources less than ,820 per year. .The report adds that, "The pharmaceutical industry has already shattered records this year, spending an unprecedented million to lobby the federal government in the first three months of this year, according to the CSP, including .7 million from PhRMA. Stephen Ubl, the CEO of PhRMA, criticized H.R. 3 last month, claiming it would ‘destroy an estimated one million American jobs.' The U.S. Chamber of Commerce, the biggest lobbying spender this year, has also come out against the bill, comparing it to ‘government price controls' and claiming it would cost hundreds of thousands of jobs. .Few employers outside the federal government and the military have taken up the option. Costco Wholesale Corp., United Parcel Service Inc. and FedEx Corp. are among employers that have said they aren't participating.